Changing Trends in the Seroprevalence of Leptospirosis in Kelambakkam: A Ten-Year Retrospective Study
Abstract
Introduction: Leptospirosis is a zoonotic infection affecting humans. The main sources of infection are animal reservoir hosts and man is the accidental host in the disease transmission process. The diagnosis is usually made by microscopy, culture, molecular techniques, and serological tests like ELISA, MAT (Microscopic Agglutination Test) and MSAT (Macroscopic Slide Agglutination Test). The ELISA method to detect IgM antibodies is used as a good cost-effective testing method. An increasing titre of IgM antibody is a sign of active leptospirosis.
Aims and Objectives: The study aimed to evaluate the seroprevalence of Leptospirainfection over a 10-year period in a tertiary care hospital located in Kelambakkam village in Chengalpattu district.
Material and Method: The samples were tested for the presence of specific Leptospira IgM antibodies in the patient’s serum using the Panbio Leptospira IgM ELISA kit. The samples were reported as positive/ negative/ equivocal accordingly.
Results: This retrospective study included a total of 2035 patients, clinically suspected of leptospirosis, over a 10-year period from 2011 to 2021. 186 patients tested positive for specific IgM antibodies by ELISA method,giving an overall prevalence rate of 9.14%.
Conclusion: The seroprevalence of leptospirosis over a time period of more than 10 years is highlighted in our study. Clinical suspicion of leptospirosis should be kept in mind at all times, especially now during the COVID-19 pandemic. The Panbio Leptospira IgM ELISA test kit used in our study proves to be a very useful method for diagnostic purposes, especially in limited-resource settings.
How to cite this article:
Sathyakamala R, Shanmugam P, Selvabai APR. Changing Trends in the Seroprevalence of Leptospirosis in Kelambakkam: A TenYear Retrospective Study. J Commun Dis. 2022;54(2):19-27.
DOI: https://doi.org/10.24321/0019.5138.202266
References
Ananthanarayan R, Paniker C. Textbook of microbiology. 11th ed. Orient Longman; 1980.
Muhsin PV, Manjusree S, Perilacode A. Seroprevalence of leptospirosis at a tertiary care hospital. J Med Sci
Clin Res. 2017;17(1):16039-44. [Google Scholar]
Patel SS, Singh S, Sahu C, Verma H. Seroprevalence trends of leptospirosis at a tertiary care centre of North
India from 2016-2019 determined by two commercial ELISA kits. J Pure Appl Microbiol. 2020;14(2):1263-8.
[Google Scholar]
Bawane RS, Shiekh N, Ingole KV, Bhise M. Seroprevalence of leptospirosis in tertiary care hospital Solapur:
aretrospective study. Int J Appl Res. 2016;2(5):183-5.
Gupta R, Suri P. Seroprevalence of leptospirosis in a tertiary care hospital are trospective study. J
Gastrointest Infect. 2012;2(1):56-8. [Google Scholar]
Dhawan S, Althaus T, Lubell Y, Suwancharoen D, Blacksell SD. Evaluation of the Panbio Leptospira IgM ELISA
among outpatients attending primary care in Southeast Asia. Am J Trop Med Hyg. 2021 Mar;104(5):1777-81.
[PubMed] [Google Scholar]
Agrawal SK, Chaudhry R, Gupta N, Arif N, Bhadur T. Decreasing trend of seroprevalence of leptospirosis
at All India Institute of Medical Sciences New Delhi: 2014-2018. J Family Med Prim Care. 2018 NovDec;7(6):1425-8. [PubMed] [Google Scholar]
Sethi S, Sood A, Pooja, Sharma S, Sengupta C, Sharma M. Leptospirosis in northern India: a clinical and serological study. Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):822-5. [PubMed] [Google Scholar]
Chaudhry R, Saigal K, Bahadur T, Kant K, Chourasia B, Gupta N. Varied presentations of leptospirosis:
experience from a tertiary care hospital in north India. Trop Doct. 2017 Apr;47(2):128-32. [PubMed] [Google
Scholar]
Guerrier G, Hie P, Gourinat AC, Huguon E, Polfrit Y, Goarant C, D’Ortenzio E, Missotte I.Association between
age and severity to leptospirosis in children. PLoSNegl Trop Dis. 2013 Sep;7(9):e2436.[PubMed] [Google
Scholar]
Tendulkar P, Sharma D, Bairwa M, Kant R.A case of leptospiraARDS- obsession with COVID-19 leading to
delayed diagnosis of common disease. Am J Infect Dis. 2021;17(2):61-4. [Google Scholar]
Ittyachen AM. COVID-19 and leptospirosis: cytokine storm and the use of steroids. Trop Doct. 2021
Jan;51(1):128-30. [PubMed] [Google Scholar]
Zochowski WJ, Palmer MF, Coleman TJ. An evaluation of three commercial kits for use as screening methods
for the detection of leptospiral antibodies in the UK. J Clin Pathol. 2001 Jan;54(1):25-30. [PubMed] [Google
Scholar]
Desakorn V, Wuthiekanun V, Thanachartwet V, Sahassananda D, Chierakul W, Apiwattanaporn A,
Day NP, Limmathurotsakul D, Peacock SJ. Accuracy of a commercial IgM ELISA for the diagnosis of human
leptospirosis in Thailand. Am J Trop Med Hyg. 2012 Mar;86(3):524-7. [PubMed] [Google Scholar]
JayasundaraD, GamageC, Senavirathna I, Warnasekara J, Matthias MA, Vinetz JM, Agampodi S. Optimizing the
microscopic agglutination test (MAT) panel for the diagnosis of leptospirosis in a low resource, hyperendemic setting with varied microgeographic variation in reactivity. PLoS Negl Trop Dis. 2021 Jul;15(7):e0009565.
[PubMed] [Google Scholar]
Copyright (c) 2022 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
